Barclays Remains a Hold on Ingredion (INGR)
In a report released today, Benjamin Theurer from Barclays maintained a Hold rating on Ingredion, with a price target of $120.00.
Introducing TipRanks MCP for Agents
- Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools.
- Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.
According to TipRanks, Theurer is a 4-star analyst with an average return of 5.0% and a 51.94% success rate. Theurer covers the Consumer Defensive sector, focusing on stocks such as Ingredion, Pilgrim’s Pride, and Bunge Global.
The word on The Street in general, suggests a Hold analyst consensus rating for Ingredion with a $119.25 average price target.
Based on Ingredion’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $1.79 billion and a net profit of $142 million. In comparison, last year the company earned a revenue of $1.81 billion and had a net profit of $197 million
Based on the recent corporate insider activity of 120 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of INGR in relation to earlier this year. Most recently, in April 2026, Jorge Uribe, a Director at INGR sold 67.00 shares for a total of $7,548.22.
Read More on INGR:
Disclaimer & DisclosureReport an Issue
- Ingredion downgraded to Perform at Oppenheimer after Tate & Lyle bid
- Ingredion downgraded to Perform from Outperform at Oppenheimer
- Midday Fly By: Nvidia partners with SK Hynix, Campbell’s reports Q3 beat
- Video: Marvell, Flex rise after selection for S&P 500
- Ingredion announces recommended GBP 3.7B acquisition of Tate & Lyle
